Atlas Trials

Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia

Clinical trial NCT04117711 · COMPLETED

Trial details

NCT number
NCT04117711
Sponsor
Applied Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Classic Galactosemia
Start date
2019-06-21
Primary completion
2021-12-14
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.